Literature DB >> 26019452

Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.

Chao Hu1, Shi-Qiang Shen1, Zhong-Hui Cui1, Zu-Bing Chen1, Wei Li1.   

Abstract

AIM: To investigate the effect of microRNA-1 (miR-1) on tumor endothelial cells (TECs) of human hepatocellular carcinoma (HCC).
METHODS: MiR-1 specific short hairpin RNA (shRNA) was synthesized and cloned into a recombinant lentiviral vector. TECs were then infected by the miRNA-1-shRNA recombinant lentivirus. TECs were divided into three groups: a control (CON) group consisting of normal TECs without lentiviral infection, a negative control (NC) group consisting of normal TECs infected with a negative control virus, and a micro-down (MD) group consisting of normal TECs infected with the miR-1-inhibition virus containing the target gene. Silencing of miR-1 expression was quantified via quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The proliferation of TECs was detected using MTT (Thiazolyl Blue Tetrazolium Bromide) assay; the observations were continued for 5 d, and the optical density value at 490 nm was detected every day. Apoptosis was detected via flow cytometry using Annexin V-APC single staining. The migration and invasion of TECs were detected using transwell assays.
RESULTS: Lentiviral miR-1 shRNA was successfully transduced into TECs, and specifically silenced the expression of miR-1. The results of qRT-PCR showed that the expression of miR-1 was significantly decreased in the MD group (2(-ΔΔCt) = 0.57 ± 0.14) compared with the CON group (2(-ΔΔCt) = 1) and the NC group (2(-ΔΔCt) = 1.05 ± 0.13) (P < 0.01). The results of MTT assay showed that the cell proliferation was all significantly inhibited in the MD group in the 5 days compared with the CON and NC groups (P < 0.01). The results of flow cytometry showed that the apoptosis was significantly increased in the MD group (6.32% ± 0.33%) compared with the CON group (2.03% ± 0.30%) and the NC group (2.18% ± 0.15%) (P < 0.01). The ability of cell migration was significantly inhibited in the MD group (62.0 ± 5.48) compared with the CON group (99.8 ± 3.11) and the NC group (97.2 ± 3.70) (P < 0.01). The ability of invasion of TECs was also significantly inhibited in the MD group (29.8 ± 2.39) compared with the CON group (44.6 ± 3.36) and the NC group (44.4 ± 5.17) (P < 0.01).
CONCLUSION: MiR-1 might be a potential tumor activator. Inhibiting its expression could decrease proliferation, induce apoptosis, and inhibit the migration and invasion of TECs of human HCC.

Entities:  

Keywords:  Hepatocellular carcinoma; MicroRNA-1; Short hairpin RNA; Tumor endothelial cells

Mesh:

Substances:

Year:  2015        PMID: 26019452      PMCID: PMC4438022          DOI: 10.3748/wjg.v21.i19.5884

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Developmental biology. Encountering microRNAs in cell fate signaling.

Authors:  Xantha Karp; Victor Ambros
Journal:  Science       Date:  2005-11-25       Impact factor: 47.728

Review 2.  Cytokines and chemokines as regulators of angiogenesis in health and disease.

Authors:  R Benelli; G Lorusso; A Albini; D M Noonan
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

3.  Widespread changes in protein synthesis induced by microRNAs.

Authors:  Matthias Selbach; Björn Schwanhäusser; Nadine Thierfelder; Zhuo Fang; Raya Khanin; Nikolaus Rajewsky
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

4.  Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis.

Authors:  Jharna Datta; Huban Kutay; Mohd W Nasser; Gerard J Nuovo; Bo Wang; Sarmila Majumder; Chang-Gong Liu; Stefano Volinia; Carlo M Croce; Thomas D Schmittgen; Kalpana Ghoshal; Samson T Jacob
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

5.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation.

Authors:  Jian-Fu Chen; Elizabeth M Mandel; J Michael Thomson; Qiulian Wu; Thomas E Callis; Scott M Hammond; Frank L Conlon; Da-Zhi Wang
Journal:  Nat Genet       Date:  2005-12-25       Impact factor: 38.330

Review 6.  The role of immune cells in the tumor microenvironment.

Authors:  Theresa L Whiteside
Journal:  Cancer Treat Res       Date:  2006

Review 7.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors:  Hashem B El-Serag; K Lenhard Rudolph
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

8.  Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.

Authors:  Mohd W Nasser; Jharna Datta; Gerard Nuovo; Huban Kutay; Tasneem Motiwala; Sarmila Majumder; Bo Wang; Saul Suster; Samson T Jacob; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

9.  Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability.

Authors:  Christopher A Jones; Nyall R London; Haoyu Chen; Kye Won Park; Dominique Sauvaget; Rebecca A Stockton; Joshua D Wythe; Wonhee Suh; Frederic Larrieu-Lahargue; Yoh-Suke Mukouyama; Per Lindblom; Pankaj Seth; Antonio Frias; Naoyuki Nishiya; Mark H Ginsberg; Holger Gerhardt; Kang Zhang; Dean Y Li
Journal:  Nat Med       Date:  2008-03-16       Impact factor: 53.440

Review 10.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

View more
  5 in total

1.  Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.

Authors:  Kanji Furuya; Akiko Sasaki; Yuko Tsunoda; Mayumi Tsuji; Yuko Udaka; Hideto Oyamada; Hiromichi Tsuchiya; Katsuji Oguchi
Journal:  Hum Cell       Date:  2015-11-16       Impact factor: 4.174

2.  MicroRNA based Pan-Cancer Diagnosis and Treatment Recommendation.

Authors:  Nikhil Cheerla; Olivier Gevaert
Journal:  BMC Bioinformatics       Date:  2017-01-13       Impact factor: 3.169

3.  Protein expression profile and microRNA expression signature in estrogen receptor-positive and -negative breast cancers: report of two cases.

Authors:  Yuko Tsunoda; Akiko Sasaki; Naomi Sakamoto; Kou Teraoka; Rie Nakagawa; Yoshitomo Koshida; Eisuke Fukuma
Journal:  Breast Cancer (Dove Med Press)       Date:  2018-11-23

Review 4.  Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells.

Authors:  Mohamed A Nasr; Radwa Ayman Salah; M Abd Elkodous; Shimaa E Elshenawy; Nagwa El-Badri
Journal:  Front Cell Dev Biol       Date:  2019-10-17

5.  Analysis of circulating microRNAs aberrantly expressed in alcohol-induced osteonecrosis of femoral head.

Authors:  Guoju Hong; Xiaorui Han; Wei He; Jiake Xu; Ping Sun; Yingshan Shen; Qiushi Wei; Zhenqiu Chen
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.